# Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

> **NCT06506773** · — · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 79 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06506773
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-09
- **Primary completion:** 2025-11-27
- **Final completion:** 2025-11-27
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06506773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06506773, "Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06506773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*